Second-look Arthroscopic Findings of Cartilage and Meniscus Repair After Injection of Adipose-derived Regenerative Cells in Knee Osteoarthrits: Report of Two Cases
Overview
Authors
Affiliations
Background: The purpose of this study was to use second-look arthroscopic findings and clinical assessment to determine outcome in two cases of knee osteoarthritis treated by intra-articular knee injection of adipose-derived regenerative cells (ADRCs).
Case Presentation: This study involved two patients who received ADRC therapy for knee osteoarthritis and completed the six-month post-treatment follow-up period. For each treatment, 130 mL of subcutaneous adipose tissue was harvested using tumescent liposuction technique and manual aspiration of tissue from the thigh using a suction cannula under local anesthesia in the operating room. The adipose tissue harvested was processed using the Celution® Centrifuge in a dedicated cell processing room. The ADRCs were injected into the articular cavity of both knees for one patient and into a single affected knee in the second patient (three joints). Pain and knee function were assessed using a Visual Analogue Scale (VAS) and the Knee Outcome in Osteoarthritis Score (KOOS) respectively. The cartilage defect was assessed by direct visualization (arthroscopy). No serious adverse events were reported throughout follow-up. Pain and knee function were significantly improved from baseline in all treated knees at one, three and six months after ADRCs. At six-months after ADRCs treatment, the second-look arthroscopy showed that almost all the cartilage defect areas were covered by regenerated cartilage, some cartilage fibrillation area was reduced, and meniscus tear areas were repaired.
Conclusions: Cartilage and meniscus repair were observed six-months after ADRCs therapy under second-look arthroscopy. It was shown that a single administration of ADRCs might be effective as a treatment for knee osteoarthritis.
Onoi Y, Matsumoto T, Anjiki K, Hayashi S, Nakano N, Kuroda Y Stem Cell Res Ther. 2024; 15(1):325.
PMID: 39334434 PMC: 11438128. DOI: 10.1186/s13287-024-03946-3.
Huang L, Zhang S, Wu J, Guo B, Gao T, Zulfiqar Ali Shah S Signal Transduct Target Ther. 2023; 8(1):417.
PMID: 37907503 PMC: 10618459. DOI: 10.1038/s41392-023-01670-7.
Onoi Y, Matsumoto T, Sobajima S, Tsubosaka M, Hayashi S, Matsushita T Regen Ther. 2023; 24:94-102.
PMID: 37363753 PMC: 10285449. DOI: 10.1016/j.reth.2023.06.006.
Autologous Adipose-Derived Tissue Stromal Vascular Fraction (AD-tSVF) for Knee Osteoarthritis.
Vargel I, Tuncel A, Baysal N, Hartuc-Cevik I, Korkusuz F Int J Mol Sci. 2022; 23(21).
PMID: 36362308 PMC: 9658499. DOI: 10.3390/ijms232113517.
Stromal Vascular Fraction for Osteoarthritis of the Knee Regenerative Engineering.
Ude C, Shah S, Ogueri K, Nair L, Laurencin C Regen Eng Transl Med. 2022; 8(2):210-224.
PMID: 35958164 PMC: 9365234. DOI: 10.1007/s40883-021-00226-x.